DPH Vaccine Advisory Committee Framework and Recommendations for COVID-19 Vaccine Allocation, Phase 1b

A primary goal in Phase 1b is preventing deaths and the ethical and equitable distribution of vaccines. With limited vaccine supply, those least able to protect themselves should be prioritized in this phase. Vaccination in this phase will focus on those at greatest risk of getting COVID-19 and those performing critical tasks in support of society who are at a much higher risk of getting COVID-19 on their jobs.

COVID-19 Booster Shots

Updated May 8, 2023

As of April 18, 2023, COVID-19 Monovalent mRNA vaccines (Pfizer BioNtech, Comirnity ©, Moderna, Spikevax©), are no longer authorized for use in the United States. These have been replaced with new bivalent vaccines that have proven to be more effective against new and emerging COVID-19 variants.

As of June 1, 2023, DHEC Health Clinics will only administer Moderna bivalent vaccine.

Who is eligible for a booster dose or additional booster dose of bivalent COVID-19 vaccine?